Hanson & Doremus Investment Management Spdr Ser Tr Spdr S&P Biotech E Transaction History

Hanson & Doremus Investment Management

$627 Million
Q3 2024

A detailed history of Hanson & Doremus Investment Management transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 4,925 shares of XBI stock, worth $465,855. This represents 0.08% of its overall portfolio holdings.

Number of Shares

4,925

Previous 7,802 36.88%

Holding current value

$465,855

Previous $723,000 32.78%

% of portfolio

0.08%

Previous 0.12%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$90.87 - $102.43 $261,432 - $294,691	-2,877 Reduced 36.88%	4,925 $486,000
Q2 2024 Aug 08, 2024	SELL	$82.22 - $94.12 $91,017 - $104,190	-1,107 Reduced 12.43%	7,802 $723,000
Q1 2024 Apr 22, 2024	SELL	$87.05 - $102.89 $408,873 - $483,274	-4,697 Reduced 34.52%	8,909 $845,000
Q4 2023 Jan 25, 2024	SELL	$64.12 - $90.86 $622,348 - $881,887	-9,706 Reduced 41.64%	13,606 $1.21 Million
Q3 2023 Oct 24, 2023	SELL	$71.88 - $85.76 $39,102 - $46,653	-544 Reduced 2.28%	23,312 $1.7 Million
Q2 2023 Jul 18, 2023	BUY	$75.38 - $90.23 $115,632 - $138,412	1,534 Added 6.87%	23,856 $1.98 Million
Q1 2023 Apr 18, 2023	BUY	$73.13 - $91.97 $25,668 - $32,281	351 Added 1.6%	22,322 $1.7 Million
Q4 2022 Jan 18, 2023	BUY	$76.72 - $85.66 $144,617 - $161,469	1,885 Added 9.38%	21,971 $1.82 Million
Q3 2022 Oct 20, 2022	BUY	$75.06 - $94.9 $335,368 - $424,013	4,468 Added 28.61%	20,086 $1.59 Million
Q2 2022 Jul 19, 2022	BUY	$62.81 - $96.09 $151,058 - $231,096	2,405 Added 18.2%	15,618 $1.16 Million
Q1 2022 Apr 22, 2022	BUY	$81.07 - $115.44 $119,335 - $169,927	1,472 Added 12.54%	13,213 $1.19 Million
Q4 2021 Jan 20, 2022	BUY	$108.77 - $134.15 $118,994 - $146,760	1,094 Added 10.28%	11,741 $1.32 Million
Q3 2021 Oct 21, 2021	BUY	$118.69 - $138.49 $243,907 - $284,596	2,055 Added 23.92%	10,647 $0
Q2 2021 Jul 22, 2021	SELL	$122.48 - $139.69 $93,084 - $106,164	-760 Reduced 8.13%	8,592 $957,000
Q1 2021 May 03, 2021	BUY	$129.36 - $173.99 $68,560 - $92,214	530 Added 6.01%	9,352 $1.27 Million
Q4 2020 Feb 01, 2021	BUY	$110.36 - $151.14 $25,382 - $34,762	230 Added 2.68%	8,822 $1.24 Million
Q3 2020 Oct 19, 2020	BUY	$103.87 - $120.36 $151,754 - $175,845	1,461 Added 20.49%	8,592 $957,000
Q2 2020 Jul 17, 2020	SELL	$73.26 - $114.17 $6,813 - $10,617	-93 Reduced 1.29%	7,131 $798,000
Q1 2020 Apr 24, 2020	BUY	$65.95 - $98.35 $105,915 - $157,950	1,606 Added 28.59%	7,224 $0
Q4 2019 Jan 16, 2020	BUY	$74.65 - $98.46 $93,984 - $123,961	1,259 Added 28.88%	5,618 $534,000
Q3 2019 Oct 18, 2019	BUY	$76.25 - $83.86 $322,537 - $354,727	4,230 Added 3279.07%	4,359 $332,000
Q2 2019 Jul 18, 2019	BUY	N/A	129 New	129 $11,000

Others Institutions Holding XBI

# of Institutions

927

Shares Held

101M

Call Options Held

28.4M

Put Options Held

33.4M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.

Account

Hanson & Doremus Investment Management Spdr Ser Tr Spdr S&P Biotech E Transaction History